S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Home
Investing
Stocks
USA
NASDAQ
Rapport Therapeutics Inc (RAPP)
Rapport Therapeutics Inc (RAPP) Options

Rapport Therapeutics Inc (RAPP)

38.19

0.85

(2.28%)

Closed June 22 3:00PM

38.19

0.00

( 0.00% )

Pre Market: 3:00AM

Rapport Therapeutics Inc (RAPP) Options

RAPP Options Flow

Calls

Strike	Bid Price	Ask Price	Last Price	Midpoint	Change	Change %	Volume	OPEN INT	Last Trade
20.00	16.40	20.50	0.00	18.45	0.00	0.00 %	0	0	-
22.50	14.00	18.00	0.00	16.00	0.00	0.00 %	0	0	-
25.00	11.50	16.00	0.00	13.75	0.00	0.00 %	0	0	-
27.50	9.00	13.50	0.00	11.25	0.00	0.00 %	0	0	-
30.00	6.50	11.00	0.00	8.75	0.00	0.00 %	0	0	-
32.50	4.50	9.00	0.00	6.75	0.00	0.00 %	0	0	-
35.00	2.50	7.00	0.00	4.75	0.00	0.00 %	0	0	-
37.50	1.00	4.90	0.00	2.95	0.00	0.00 %	0	0	-
40.00	0.10	4.90	1.69	2.50	-0.21	-11.05 %	1	1	6/22/2026
42.50	0.10	2.50	0.00	1.30	0.00	0.00 %	0	0	-
45.00	0.10	4.90	0.00	2.50	0.00	0.00 %	0	0	-
47.50	0.10	4.90	0.00	2.50	0.00	0.00 %	0	0	-
50.00	0.05	4.90	0.00	2.475	0.00	0.00 %	0	0	-
55.00	0.00	2.30	0.00	0.00	0.00	0.00 %	0	0	-

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Puts

Strike	Bid Price	Ask Price	Last Price	Midpoint	Change	Change %	Volume	OPEN INT	Last Trade
20.00	0.00	4.90	0.00	0.00	0.00	0.00 %	0	0	-
22.50	0.00	4.90	0.00	0.00	0.00	0.00 %	0	0	-
25.00	0.05	4.90	0.00	2.475	0.00	0.00 %	0	0	-
27.50	0.20	4.90	0.00	2.55	0.00	0.00 %	0	0	-
30.00	0.10	4.90	0.00	2.50	0.00	0.00 %	0	0	-
32.50	0.45	4.90	0.00	2.675	0.00	0.00 %	0	0	-
35.00	0.70	4.90	0.00	2.80	0.00	0.00 %	0	0	-
37.50	0.10	4.90	0.00	2.50	0.00	0.00 %	0	0	-
40.00	2.50	6.00	3.65	4.25	0.00	0.00 %	0	50	-
42.50	3.50	7.50	0.00	5.50	0.00	0.00 %	0	0	-
45.00	5.50	9.50	0.00	7.50	0.00	0.00 %	0	0	-
47.50	8.00	11.50	0.00	9.75	0.00	0.00 %	0	0	-
50.00	10.00	14.00	0.00	12.00	0.00	0.00 %	0	0	-
55.00	14.50	19.00	0.00	16.75	0.00	0.00 %	0	0	-

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
MBRXMoleculin Biotech Inc	US$ 6.44 (106.41%)	1.06M
CIITTianci International Inc	US$ 0.8983 (83.33%)	7.52M
ORISOriental Rise Holdings Ltd	US$ 3.90 (61.16%)	287k
ADTXAditxt Inc	US$ 0.0285 (48.44%)	50.48M
DTSSDatasea Intelligent Technology Ltd	US$ 0.93 (22.38%)	44.93k
NXTSNexentis Techgnologies Inc	US$ 7.34 (-43.54%)	29.82k
WHLRWheeler Real Estate Investment Trust Inc	US$ 2.36 (-37.89%)	2.07k
WETOWetour Robotics Ltd	US$ 0.8261 (-28.17%)	400
KIDZKIDZ AI Inc	US$ 1.14 (-20.28%)	6.35k
TNONTenon Medical Inc	US$ 0.4999 (-19.57%)	87.28k
ADTXAditxt Inc	US$ 0.0285 (48.44%)	50.48M
GDCGD Culture Group Ltd	US$ 0.0248 (22.17%)	42.42M
CIITTianci International Inc	US$ 0.8983 (83.33%)	7.52M
INLFINLIF Limited	US$ 0.10 (-9.91%)	3.45M
MBRXMoleculin Biotech Inc	US$ 6.44 (106.41%)	1.06M

US Market News

US Market News 5 minutes ago

Rockwell Automation Announces Cranswick to Improve Production-Line Efficiency with Precision Robotic Pick-and-Place TechnologyJune 23, 2026 4:00 AM
PR Newswire (US) Gourmet-food-maker automates end-of-line packaging process using autonox robots, in coll

Methinks

Methinks 6 minutes ago

I am keeping an eye on Infineon stocks. Up by 200% in the last few months. They are developing the TPM in Europe.

boston127

boston127 7 minutes ago

Thanks for this. I will buy

get into this one after 10 AM. The other one is flying again, beginning right at 4 AM.

100lbStriper

100lbStriper 9 minutes ago

franks summary.........„The Director further explains exceptional circumstances warranting an additional extension may include: dismissal of all or substantially all claims in a co-pending litigation, findings of fact and conclusions of law that render all or substantially all challenged claims inva

boston127

boston127 12 minutes ago

It is 4 AM, and we are flying

Price is .026, up 34%, and volume is 76M.

100lbStriper

100lbStriper 12 minutes ago

SilviaJ $NLST Trend Force expects the memory market's revenue to reach $889.3 billion in 2026, while the 2027 forecast stands at a whopping $1.28 trillion.

Counterpoint Research: The DRAM market's revenue is anticipated to increase by 4x in 2026 to $618.7 billion, followed by a 46%

gitreal

gitreal 15 minutes ago

Don't go away mad. Either respond to the charges, or block them so you don't have to see them. Fleeing from the board completely only makes it seem that the charges are true. Are they?

We need those reports on your first-person visits to the Bishop plant, they've been very inform

100lbStriper

100lbStriper 16 minutes ago

UNITED STATES PATENT AND TRADEMARK OFFICE https://www.uspto.gov/sites/default/files/documents/ipr2025-01072-dr-paper_30.pdf

100lbStriper

100lbStriper 21 minutes ago

and to think i could of dumped those roof shares at better than 350!!! free roof, profit, and principal back with taxs paid, but noooooo..........i want more!!!!!!!

mm41

mm41 27 minutes ago

S&P 500 vs. S&P 493: Where smart money is buying in silence right now
Read the Full article here https://www.linkedin.com/pulse/sp-500-illusion-you-reading-headlines-did-actually-do-mirjana-garison-6cz0e/

ducci1

ducci1 43 minutes ago

Charts: SPY Support--- 23% Retrace Fib at 730.31 !

ducci1

ducci1 49 minutes ago

Charts: Falling Channels Confirmed-----ES Lower Trendline 7395----SPY Lower T/L 733.45 !

nowwhat2

nowwhat2 54 minutes ago

Remarkable reporting (if I do say so myself) he-he

https://investorshub.advfn.com/uimage/uploads/2026/6/23/ysrgibtc_june_22_1m_1045pm_SUMMARY_66666_FOMC_GUTSY.jpg

:45 minutes later and.....
https://investorshub.advfn.com/uimage/uploads/2026/6/23/guikmbtc_june_2

US Market News

US Market News 1 hour ago

LiveRamp Partners with Adobe to Bring Commerce Purchase Data into GenStudio for Commerce Media NetworksJune 23, 2026 3:00 AM
Business WireAdobe GenStudio for Commerce Media Networks addresses key creative, data, and activation needsLiveRamp (NYSE: RAMP),

US Market News

US Market News 1 hour ago

AbbVie Announces European Commission Approval of SKYRIZI® (risankizumab) for the Treatment of Pediatric Patients with Moderate to Severe Plaque PsoriasisJune 23, 2026 3:00 AM
PR Newswire (US) SKYRIZI® (risankizumab) expands i

US Market News

US Market News 1 hour ago

AbbVie Announces European Commission Approval of SKYRIZI® (risankizumab) for the Treatment of Pediatric Patients with Moderate to Severe Plaque PsoriasisJune 23, 2026 3:00 AM
PR Newswire (US) SKYRIZI® (risankizumab) expands i

US Market News

US Market News 1 hour ago

Clarivate Releases 2025 Sustainability ReportJune 23, 2026 3:00 AM
PR Newswire (US) New report highlights progress against goals and a decline in total carbon emissions class="legendSpanClass"LONDON, class="legendSpanClass"June 23, 2026

nowwhat2

nowwhat2 1 hour ago

Remarkable reporting (if I do say so myself) he-he

https://investorshub.advfn.com/uimage/uploads/2026/6/23/ysrgibtc_june_22_1m_1045pm_SUMMARY_66666_FOMC_GUTSY.jpg

:45 minutes later and.....
https://investorshub.advfn.com/uimage/uploads/2026/6/23/guikmbtc_june_2

WooptdooU

WooptdooU 1 hour ago

Seeking Alpha article is INCREDIBLY POSITIVE, just read it!!!
It is written Nearly ALL POSITIVE facts and negative opinion, just a real whimper level of faith, trust and risk tolerance. It is also Just incredible to read the nearly bear case scenario of present value pricing lists a HIGHER pr

US Market News

US Market News 1 hour ago

Tradeweb Launches Spread Trading for European Credit PortfoliosJune 23, 2026 3:00 AM
Business Wire Enables portfolio-level execution on a spread within a single, integrated workflow Tradeweb Markets Inc. (Nasdaq: TW), a global leader in electronic tradi

shajandr

shajandr 1 hour ago

As usual, you're a funny guy.

Like a clown.

https://www.youtube.com/watch?v=Pfcy15ZUE2c

Tom turtles

Tom turtles 1 hour ago

What a monster.....Holding 50k from .,28

Rapport Therapeutics

Swire Pacific (PK)

Barings Core Spain Socimi

ProShares UltraShort Euro

ARS Pharmaceuticals

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

ADVFN

Already have an account? Sign in

Don't have an account? Sign up

By registering, I confirm I have read, understand, and agree to ADVFN's Terms and Conditions and that I am a private investor.